AlphAIAlphAI — Financial news for AI agents
SEC EDGAR$CBRS

Patel Yagnesh sold $697K of CBRS

Patel Yagnesh (Chief Accounting Officer) sold 4,000 shares of Cerebras Systems Inc. (CBRS) at an average of $174.20 ($161.61–$189.36, $0.70M total) across 15 trades over 2026-06-25 to 2026-06-26.

Original reporting
SEC EDGAR · Patel Yagnesh
Published Jun 29, 2026, 8:49 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 29, 2026, 8:55 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$CBRS
Neutral
medium confidence
Mentioned
$CBRS
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CBRSNeutralLow
01

Why it matters

The newest fact is the CFO’s/CAO’s open-market sale totaling ~$696.8K at a range of prices, leaving the insider with 0 shares post-transaction.

02

Market read

Traders may monitor for follow-on insider activity, but there is no accompanying fundamental update in the filing text.

03

What to watch

The disclosure lacks context on taxes, diversification needs, or whether other insiders/large holders acted around the same time; without that, directional inference is weak.

Relevance 5/10Novelty 5/10Timing: filed after-hours on 2026-06-29 (SEC Form 4 disclosure)

Background

The article is an SEC Form 4 insider transaction disclosure for Cerebras Systems Inc. (CBRS).

Company-level read

Ticker impact

$CBRSNeutralMedium confidence
Context

Cerebras Systems CFO Patel Yagnesh sold ~$696.8K of CBRS shares (4,000 total) across 15 trades at $161.61–$189.36.

Expected impact

Likely limited/short-lived impact; any effect would be sentiment-driven rather than a re-rating catalyst.

Evidence & confidence

The filing is a Form 4 insider sale with no 10b5-1 plan stated and no accompanying company-specific news (earnings, guidance, deal, or regulatory action).

Market effects

Sector

Minimal; this is company-specific insider activity with no sector-wide regulatory/product signal.

Regional

None indicated.

Global

None indicated.

Counterpoint

What could challenge this read

The sale could be routine liquidity/portfolio rebalancing (no 10b5-1 plan is stated, but insider sales are often non-informational).

Key entities

  • issuer
    Cerebras Systems Inc.

    Company whose insider transaction is disclosed on SEC Form 4 (CBRS).

  • insider
    Patel Yagnesh

    Chief Accounting Officer reporting the sale of CBRS shares.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

CBRS insider trading history →

Related articles

$CBRSMed

Why Cerebras Systems Stock Is Plummeting Today

Cerebras Systems (CBRS) shares fell 9.2% after UBS cut its price target by 24% to $250, citing tempered expectations. Despite the reduction, UBS maintains a buy rating, noting potential upside from OpenAI demand and AWS adoption. The stock has also faced criticism from Culper Research, which took a short position. Cerebras is set to report Q3 earnings on Nov. 12.

finance.yahoo.com
$CBRSMed

Why is Cerebras Systems stock sliding today?

Cerebras Systems (CBRS) stock fell 8.3% to a 52-week low of $98.50 after UBS cut its price target to $250 from $330, citing reduced near-term conviction. The decline follows a short-seller report alleging chip degradation and upcoming share unlocks. The stock is down 70% from its high, but analysts maintain Buy ratings.

investing.com
$CBRSHigh

Cerebras Stock Falls as Short Seller Questions Chip Lifespan

Cerebras Systems (CBRS) fell 5.77% after short seller Culper Research alleged its AI chips have a lifespan of 1.5 to 2.5 years and questioned its technology claims. Cerebras has not responded. The drop follows a lockup expiration and reverses part of a previous rally. The stock is far below its 52-week high of $386.34.

finance.yahoo.com
$CBRSHigh

Cerebras Gains 10% on Oracle Cloud Deal as “AI Inference Demands Choice”

Cerebras Systems (CBRS) shares rose 10% and Oracle (ORCL) gained 4% on Oct. 27 after Oracle announced plans to offer Cerebras' AI inference on its cloud starting in 2027. The deal aims to provide customers with more AI chip options. Analysts estimate Cerebras' 2027 revenue at $2.95 billion, though no deal value was disclosed. Cerebras trades at roughly half its average forward price/sales multiple since its IPO.

finance.yahoo.com
$CBRSMed

Why Cerebras Systems Stock Jumped on Tuesday

Cerebras Systems (CBRS) stock rose 10.1% after announcing a partnership with Oracle (ORCL) to offer its AI chip technology to Oracle Cloud Infrastructure customers. The company's Wafer-Scale Engine (WSE) is promoted for its large size and reduced latency. Cerebras reported a 287% year-over-year increase in cloud revenue to $128 million in Q2, but continues to incur losses.

finance.yahoo.com